Molecular classification and clonal differentiation of hepatocellular carcinoma: the step forward for patient selection for liver transplantation

References

• Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J. Clin.55(2), 74–108 (2005).
   PubMed Web of Science ®Google Scholar
• Altekruse SF, McGlynn KA, Reichman ME. Hepatocellular carcinoma incidence, mortality, and survival trends in the United States from 1975 to 2005. J. Clin. Oncol.27(9), 1485–1491 (2009).
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention (CDC). Hepatocellular carcinoma – United States, 2001–2006. MMWR Morb. Mortal. Wkly. Rep.59(17), 517–520 (2010).
   PubMedGoogle Scholar
• Perz JF, Armstrong GL, Farrington LA, Hutin YJ, Bell BP. The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide. J. Hepatol.45(4), 529–538 (2006).
   PubMed Web of Science ®Google Scholar
• Jain S, Singhal S, Lee P, Xu R. Molecular genetics of hepatocellular neoplasia. Am. J. Transl. Res.2(1), 105–118 (2010).
   PubMedGoogle Scholar
• Bosch FX, Ribes J, Cleries R, Diaz M. Epidemiology of hepatocellular carcinoma. Clin. Liver Dis.9(2), 191–211 (2005).
   PubMed Web of Science ®Google Scholar
• El-Serag HB, Rudolph KL. Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology132(7), 2557–2576 (2007).
   PubMed Web of Science ®Google Scholar
• Kim WR, Brown RS Jr, Terrault NA, El-Serag H. Burden of liver disease in the United States: summary of a workshop. Hepatology36(1), 227–242 (2002).
   PubMed Web of Science ®Google Scholar
• Mazzaferro V, Regalia E, Doci R et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N. Engl. J. Med.334(11), 693–699 (1996).
   PubMed Web of Science ®Google Scholar
• Yao FY, Ferrell L, Bass NM et al. Liver transplantation for hepatocellular carcinoma: expansion of the tumor size limits does not adversely impact survival. Hepatology33(6), 1394–1403 (2001).
   PubMed Web of Science ®Google Scholar
• Llovet JM, Schwartz M, Fuster J, Bruix J. Expanded criteria for hepatocellular carcinoma through down-staging prior to liver transplantation: not yet there. Semin. Liver Dis.26(3), 248–253 (2006).
   PubMedGoogle Scholar
• Freeman RB, Mithoefer A, Ruthazer R et al. Optimizing staging for hepatocellular carcinoma before liver transplantation: a retrospective analysis of the UNOS/OPTN database. Liver Transpl.12(10), 1504–1511 (2006).
   PubMed Web of Science ®Google Scholar
• Hanna RF, Kased N, Kwan SW et al. Double-contrast MRI for accurate staging of hepatocellular carcinoma in patients with cirrhosis. Am. J. Roentgenol.190(1), 47–57 (2008).
   PubMedGoogle Scholar
• Bruix J, Hessheimer AJ, Forner A, Boix L, Vilana R, Llovet JM. New aspects of diagnosis and therapy of hepatocellular carcinoma. Oncogene25(27), 3848–3856 (2006).
   PubMed Web of Science ®Google Scholar
• Washburn K. Model for End Stage Liver Disease and hepatocellular carcinoma: a moving target. Transplant. Rev. (Orlando).24(1), 11–17 (2010).
   PubMedGoogle Scholar
• Ishizaki Y, Kawasaki S. The evolution of liver transplantation for hepatocellular carcinoma (past, present, and future). J. Gastroenterol.43(1), 18–26 (2008).
   PubMedGoogle Scholar
• Yao FY, Xiao L, Bass NM, Kerlan R, Ascher NL, Roberts JP. Liver transplantation for hepatocellular carcinoma: validation of the UCSF-expanded criteria based on preoperative imaging. Am. J. Transplant.7(11), 2587–2596 (2007).
   PubMed Web of Science ®Google Scholar
• Yao FY. Expanded criteria for liver transplantation in patients with hepatocellular carcinoma. Hepatol. Res.37(Suppl. 2), S267–S274 (2007).
   Google Scholar
• Duffy JP, Vardanian A, Benjamin E et al. Liver transplantation criteria for hepatocellular carcinoma should be expanded: a 22-year experience with 467 patients at UCLA. Ann. Surg.246(3), 502–509; discussion 509–5011 (2007).
   PubMed Web of Science ®Google Scholar
• Mazzaferro V, Llovet JM, Miceli R et al. Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis. Lancet Oncol.10(1), 35–43 (2009).
   PubMed Web of Science ®Google Scholar
• Raj A, McCall J, Gane E. Validation of the ‘Metroticket’ predictor in a cohort of patients transplanted for predominantly HBV-related hepatocellular carcinoma. J. Hepatol. DOI: 10.1016/j.jhep.2011.01.052 (2011) (Epub ahead of print).
   PubMedGoogle Scholar
• Decaens T, Roudot-Thoraval F, Hadni-Bresson S et al. Impact of UCSF criteria according to pre- and post-OLT tumor features: analysis of 479 patients listed for HCC with a short waiting time. Liver Transpl.12(12), 1761–1769 (2006).
   PubMed Web of Science ®Google Scholar
• Ju MK, Choi GH, Huh KH et al. UCSF criteria by pre-transplant radiologic study can not assure similar post-transplant results of hepatocellular carcinoma within Milan criteria. Hepatogastroenterology57(101), 819–825 (2010).
   PubMedGoogle Scholar
• Toso C, Trotter J, Wei A et al. Total tumor volume predicts risk of recurrence following liver transplantation in patients with hepatocellular carcinoma. Liver Transpl.14(8), 1107–1115 (2008).
   PubMed Web of Science ®Google Scholar
• Toso C, Asthana S, Bigam DL, Shapiro AM, Kneteman NM. Reassessing selection criteria prior to liver transplantation for hepatocellular carcinoma utilizing the Scientific Registry of Transplant Recipients database. Hepatology49(3), 832–838 (2009).
   PubMed Web of Science ®Google Scholar
• Macaron C, Hanouneh IA, Lopez R, Aucejo F, Zein NN. Total tumor volume predicts recurrence of hepatocellular carcinoma after liver transplantation in patients beyond Milan or UCSF criteria. Transplant. Proc.42(10), 4585–4592 (2010).
   PubMed Web of Science ®Google Scholar
• Lu CH, Chen CL, Cheng YF et al. Correlation between imaging and pathologic findings in explanted livers of hepatocellular carcinoma cases. Transplant. Proc.42(3), 830–833 (2010).
   PubMedGoogle Scholar
• Ayyappan AP, Jhaveri KS. CT and MRI of hepatocellular carcinoma: an update. Expert Rev. Anticancer Ther.10(4), 507–519 (2010).
   PubMed Web of Science ®Google Scholar
• Yu NC, Chaudhari V, Raman SS et al. CT and MRI improve detection of hepatocellular carcinoma, compared with ultrasound alone, in patients with cirrhosis. Clin. Gastroenterol. Hepatol.9(2), 161–167 (2011).
   PubMed Web of Science ®Google Scholar
• Schmitt TM, Kumer SC, Shah N, Argo CK, Northup PG. Liver transplantation for T3 lesions has higher waiting list mortality but similar survival compared to T1 and T2 lesions. Ann. Hepatol.9(4), 390–396 (2010).
   PubMedGoogle Scholar
• Iavarone M, Sangiovanni A, Forzenigo LV et al. Diagnosis of hepatocellular carcinoma in cirrhosis by dynamic contrast imaging: the importance of tumor cell differentiation. Hepatology52(5), 1723–1730 (2010).
   PubMed Web of Science ®Google Scholar
• Colecchia A, Montrone L, Scaioli E, Festi D. Percutaneous liver biopsy in the clinical management of hepatocellular carcinoma: back to the future. Hepatology (2010).
   Google Scholar
• Cillo U, Vitale A, Bassanello M et al. Liver transplantation for the treatment of moderately or well-differentiated hepatocellular carcinoma. Ann. Surg.239(2), 150–159 (2004).
   PubMed Web of Science ®Google Scholar
• Cillo U, Vitale A, Grigoletto F et al. Intention-to-treat analysis of liver transplantation in selected, aggressively treated HCC patients exceeding the Milan criteria. Am. J. Transplant.7(4), 972–981 (2007).
   PubMedGoogle Scholar
• Vakili K, Pomposelli JJ, Cheah YL et al. Living donor liver transplantation for hepatocellular carcinoma: increased recurrence but improved survival. Liver Transpl.15(12), 1861–1866 (2009).
   PubMedGoogle Scholar
• Dudek K, Kornasiewicz O, Remiszewski P et al. Impact of tumor characteristic on the outcome of liver transplantation in patients with hepatocellular carcinoma. Transplant. Proc.41(8), 3135–3137 (2009).
   PubMedGoogle Scholar
• Marshall AE, Rushbrook SM, Vowler SL et al. Tumor recurrence following liver transplantation for hepatocellular carcinoma: role of tumor proliferation status. Liver Transpl.16(3), 279–288 (2010).
   PubMedGoogle Scholar
• Lai Q, Merli M, Ginanni Corradini S et al. Predictive factors of recurrence of hepatocellular carcinoma after liver transplantation: a multivariate analysis. Transplant. Proc.41(4), 1306–1309 (2009).
   PubMedGoogle Scholar
• Bruix J, Sherman M. Management of hepatocellular carcinoma: an update. Hepatology53(3), 1020–1022 (2011).
   PubMed Web of Science ®Google Scholar
• International Consensus Group for Hepatocellular Neoplasia. The International Consensus Group for Hepatocellular Neoplasia. Pathologic diagnosis of early hepatocellular carcinoma: a report of the international consensus group for hepatocellular neoplasia. Hepatology49(2), 658–664 (2009).
   PubMed Web of Science ®Google Scholar
• Cucchetti A, Piscaglia F, Grigioni AD et al. Preoperative prediction of hepatocellular carcinoma tumor grade and micro-vascular invasion by means of artificial neural network: a pilot study. J. Hepatol.52(6), 880–888 (2010).
   PubMed Web of Science ®Google Scholar
• Pawlik TM, Gleisner AL, Anders RA, Assumpcao L, Maley W, Choti MA. Preoperative assessment of hepatocellular carcinoma tumor grade using needle biopsy: implications for transplant eligibility. Ann. Surg.245(3), 435–442 (2007).
   PubMed Web of Science ®Google Scholar
• Morimoto O, Nagano H, Sakon M et al. Diagnosis of intrahepatic metastasis and multicentric carcinogenesis by microsatellite loss of heterozygosity in patients with multiple and recurrent hepatocellular carcinomas. J. Hepatol.39(2), 215–221 (2003).
   PubMed Web of Science ®Google Scholar
• Utsunomiya T, Shimada M, Imura S, Morine Y, Ikemoto T, Mori M. Molecular signatures of noncancerous liver tissue can predict the risk for late recurrence of hepatocellular carcinoma. J. Gastroenterol.45(2), 146–152 (2010).
   PubMedGoogle Scholar
• Roncalli M, Park YN, Di Tommaso L. Histopathological classification of hepatocellular carcinoma. Dig. Liver Dis.42(Suppl. 3), S228– S234 (2010).
   Google Scholar
• Miyagawa S, Kawasaki S, Makuuchi M. Comparison of the characteristics of hepatocellular carcinoma between hepatitis B and C viral infection: tumor multicentricity in cirrhotic liver with hepatitis C. Hepatology24(2), 307–310 (1996).
   PubMedGoogle Scholar
• van der Sijp JR, van Meerbeeck JP, Maat AP et al. Determination of the molecular relationship between multiple tumors within one patient is of clinical importance. J. Clin. Oncol.20(4), 1105–1114 (2002).
   PubMedGoogle Scholar
• Chen YJ, Yeh SH, Chen JT et al. Chromosomal changes and clonality relationship between primary and recurrent hepatocellular carcinoma. Gastroenterology119(2), 431–440 (2000).
   PubMed Web of Science ®Google Scholar
• Ng IO, Guan XY, Poon RT, Fan ST, Lee JM. Determination of the molecular relationship between multiple tumour nodules in hepatocellular carcinoma differentiates multicentric origin from intrahepatic metastasis. J. Pathol.199(3), 345–353 (2003).
   PubMed Web of Science ®Google Scholar
• Finkelstein SD, Marsh W, Demetris AJ et al. Microdissection-based allelotyping discriminates de novo tumor from intrahepatic spread in hepatocellular carcinoma. Hepatology37(4), 871–879 (2003).
   PubMedGoogle Scholar
• Lin YW, Lee HS, Chen CH, Huang GT, Lee PH, Sheu JC. Clonality analysis of multiple hepatocellular carcinomas by loss of heterozygosity pattern determined by chromosomes 16q and 13q. J. Gastroenterol. Hepatol.20(4), 536–546 (2005).
   PubMedGoogle Scholar
• Li Q, Wang J, Juzi JT et al. Clonality analysis for multicentric origin and intrahepatic metastasis in recurrent and primary hepatocellular carcinoma. J. Gastrointest. Surg.12(9), 1540–1547 (2008).
   PubMed Web of Science ®Google Scholar
• Taniguchi K, Yamada T, Sasaki Y, Kato K. Genetic and epigenetic characteristics of human multiple hepatocellular carcinoma. BMC Cancer10, 530 (2010).
   PubMedGoogle Scholar
• Wong QW, Wong N, Lai PB, To KF, Wong N. Clonal relationship of tumor nodules in hepatocellular carcinoma: a hierarchical clustering analysis of comparative genomic hybridization data. Hum. Pathol.36(8), 893–898 (2005).
   PubMedGoogle Scholar
• Wu JC, Sun BS, Ren N, Ye QH, Qin LX. Genomic aberrations in hepatocellular carcinoma related to osteopontin expression detected by array-CGH. J. Cancer Res. Clin. Oncol.136(4), 595–601 (2010).
   PubMedGoogle Scholar
• Wong CM, Lee JM, Lau TC, Fan ST, Ng IO. Clinicopathological significance of loss of heterozygosity on chromosome 13q in hepatocellular carcinoma. Clin. Cancer Res.8(7), 2266–2272 (2002).
   PubMed Web of Science ®Google Scholar
• Sherman M. Hepatocellular carcinoma: epidemiology, surveillance, and diagnosis. Semin. Liver Dis.30(1), 3–16 (2010).
   PubMed Web of Science ®Google Scholar
• Nomoto S, Kinoshita T, Kato K et al. Hypermethylation of multiple genes as clonal markers in multicentric hepatocellular carcinoma. Br. J. Cancer97(9), 1260–1265 (2007).
   PubMedGoogle Scholar
• Sawyers CL. The cancer biomarker problem. Nature452(7187), 548–552 (2008).
   PubMed Web of Science ®Google Scholar
• van’t Veer LJ, Bernards R. Enabling personalized cancer medicine through analysis of gene-expression patterns. Nature452(7187), 564–570 (2008).
   PubMed Web of Science ®Google Scholar
• Kim K, Zakharkin SO, Allison DB. Expectations, validity, and reality in gene expression profiling. J. Clin. Epidemiol.63(9), 950–959 (2010).
   PubMedGoogle Scholar
• Imbeaud S, Ladeiro Y, Zucman-Rossi J. Identification of novel oncogenes and tumor suppressors in hepatocellular carcinoma. Semin. Liver Dis.30(1), 75–86 (2010).
   PubMedGoogle Scholar
• Yu GR, Kim SH, Park SH et al. Identification of molecular markers for the oncogenic differentiation of hepatocellular carcinoma. Exp. Mol. Med.39(5), 641–652 (2007).
   PubMedGoogle Scholar
• Mas VR, Maluf DG, Archer KJ et al. Genes involved in viral carcinogenesis and tumor initiation in hepatitis C virus-induced hepatocellular carcinoma. Mol. Med.15(3–4), 85–94 (2009).
   PubMed Web of Science ®Google Scholar
• Boyault S, Rickman DS, de Reynies A et al. Transcriptome classification of HCC is related to gene alterations and to new therapeutic targets. Hepatology45(1), 42–52 (2007).
   PubMed Web of Science ®Google Scholar
• Chiang DY, Villanueva A, Hoshida Y et al. Focal gains of VEGFA and molecular classification of hepatocellular carcinoma. Cancer Res.68(16), 6779–6788 (2008).
   PubMed Web of Science ®Google Scholar
• Hoshida Y, Nijman SM, Kobayashi M et al. Integrative transcriptome analysis reveals common molecular subclasses of human hepatocellular carcinoma. Cancer Res.69(18), 7385–7392 (2009).
   PubMed Web of Science ®Google Scholar
• Toffanin S, Hoshida Y, Lachenmayer A et al. MicroRNA-based classification of hepatocellular carcinoma and oncogenic role of miR-517a. Gastroenterology (2011).
   Google Scholar
• Villanueva A, Hoshida Y, Battiston C et al. Combining clinical, pathology, and gene expression data to predict recurrence of hepatocellular carcinoma. Gastroenterology140(5), 1501–1512.e2 (2011).
   PubMed Web of Science ®Google Scholar
• Hoshida Y, Villanueva A, Kobayashi M et al. Gene expression in fixed tissues and outcome in hepatocellular carcinoma. N. Engl. J. Med.359(19), 1995–2004 (2008).
   PubMed Web of Science ®Google Scholar
• Mas VR, Maluf DG, Dumur CI et al. Molecular techniques for identifying HCC origin and biology after orthotopic liver transplantation. Diagn. Mol. Pathol.15(2), 90–94 (2006).
   PubMedGoogle Scholar
• Mas VR, Fisher RA, Archer KJ et al. Genes associated with progression and recurrence of hepatocellular carcinoma in hepatitis C patients waiting and undergoing liver transplantation: preliminary results. Transplantation83(7), 973–981 (2007).
   PubMed Web of Science ®Google Scholar
• Nakata T, Seki N, Miwa S et al. Identification of genes associated with multiple nodules in hepatocellular carcinoma using cDNA microarray: multicentric occurrence or intrahepatic metastasis? Hepatogastroenterology55(84), 865–872 (2008).
   PubMedGoogle Scholar
• Kennedy RE, Kerns RT, Kong X, Archer KJ, Miles MF. SScore: an R package for detecting differential gene expression without gene expression summaries. Bioinformatics22(10), 1272–1274 (2006).
   PubMedGoogle Scholar
• Shi L, Perkins RG, Fang H, Tong W. Reproducible and reliable microarray results through quality control: good laboratory proficiency and appropriate data analysis practices are essential. Curr. Opin. Biotechnol.19(1), 10–18 (2008).
   PubMedGoogle Scholar
• Bammler T, Beyer RP, Bhattacharya S et al. Standardizing global gene expression analysis between laboratories and across platforms. Nat. Methods2(5), 351–356 (2005).
   PubMed Web of Science ®Google Scholar
• Irizarry RA, Warren D, Spencer F et al. Multiple-laboratory comparison of microarray platforms. Nat. Methods2(5), 345–350 (2005).
   PubMed Web of Science ®Google Scholar
• Larkin JE, Frank BC, Gavras H, Sultana R, Quackenbush J. Independence and reproducibility across microarray platforms. Nat. Methods2(5), 337–344 (2005).
   PubMed Web of Science ®Google Scholar